Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hay fever can send work productivity down the drain

27.04.2007
Employers can blame hay fever for the loss of millions of hours of work productivity this spring.

A new study of nearly 600 people with hay fever symptoms, including sneezing, watery eyes and runny and itchy noses, found that workers missed an hour of work per week during peak hay fever season.

While missing an hour of work a week may seem small, consider that 20 to 50 million Americans suffer from at least some symptoms related to hay fever, or allergic rhinitis, said Sheryl Szeinbach, the study's lead author and a professor of pharmacy practice and administration at Ohio State University.

“That means the potential loss of millions of hours of work productivity, not to mention the associated economic costs,” she said. Some estimates suggest that nearly 4 million days of missed work each year due to allergy symptoms.

Hay fever symptoms can disrupt all areas of life, and study participants cited a lack of sleep and a negative impact on their overall health as the two main reasons for missing work.

Szeinbach suggests that people who suspect they have hay fever get an allergy test, either from a family doctor or an allergist. In previous work, she found that some people with allergy-like symptoms don't actually have allergies. Almost anything can cause allergy-type symptoms - perfumes, sinus infections, exercise, dust, cold air – even if a person doesn't have an allergy.

“Diagnostic testing followed by the right kind of treatment may mean less time out of work,” she said.

The study currently appears on the website for the Primary Care Respiratory Journal.

Szeinbach and her colleagues collected questionnaires from 577 people whose medical and prescription records showed a diagnosis of allergic rhinitis. Participants were asked about the severity and type of allergy symptoms they had, and whether or not they had seen a physician for treatment.

The researchers placed participant responses into one of three groups: 240 patients received care from a family physician; 172 patients saw an allergist for treatment; and 165 chose to self-manage their symptoms (most of the patients in this latter group had been formally tested for allergies by a physician.)

Work time missed due to allergy symptoms ranged from zero to 32 hours a week. Although collectively the participants missed an average of one hour of work per week during the year-long study, most hours were missed during peak hay fever seasons – namely spring and fall. In reality, this may result in missing a couple to several days of work a week during allergy season.

People under the care of a family physician reported a greater severity of symptoms than did patients treated by an allergist as well as those who self-managed their allergy symptoms.

“Family physicians tend to be the gatekeepers to allergists, and as such are more likely to have initial contact with allergy patients,” Szeinbach said. “So it makes sense that family physicians would see patients with a broad spectrum of allergy symptoms.

“Both kinds of physicians have access to thorough diagnostic tests, and can also prescribe heavy-duty allergy drugs, such as steroids that help block the body's natural reaction to allergens,” she continued. Participants who self-managed their allergies relied on over-the-counter products to control their milder symptoms.

A lack of sleep and a decrease in quality of life had the greatest impact on a person's ability to work, regardless of the treatment group they were in. Participants also cited watery eyes and sneezing as having a moderately negative effect on their productivity at work.

While hay fever may remain a fact of life for millions of people, Szeinbach points out the importance of a proper diagnosis. The majority of study participants (405) had a traditional skin-prick test, in which a drop of allergen is placed on a patient's arm or back. The physician then pricks the skin through the drop, which lets the allergen enter the body. The doctor and patient then wait for a reaction, which could indicate an allergy.

About one out of five participants in the study underwent a blood test that evaluates the reaction of immunoglobulin E (IgE) to specific allergens, such as pollen from grass and trees. IgE is an antibody that triggers allergic reactions. In a previous study, Szeinbach found that the ImmunoCAP IgE blood test was more accurate in diagnosing allergies when compared to other specific IgE blood tests.

While IgE testing is traditionally the realm of allergists, more and more family physicians are starting to use it, she said. But patients who think they may have allergies need to ask if their family doctor has access to this test.

“Managed care protocols still need to be changed to allow for the increased use of this test,” Szeinbach said. “The change in practice could result in far fewer missed workdays.”

She conducted the study with Ohio State colleagues Enrique Seoane-Vazquez, assistant professor of pharmacy practice and administration, and Andrew Beyer, a pharmacy doctoral student, and also with P. Brock Williams with the University of Missouri Medical School in Kansas City .

Funding for this study was provided by an unrestricted educational grant from Phadia US Inc., manufacturer of the ImmunoCAP IgE test. Szeinbach and her colleagues have no ties to the company beyond the scope of this work.

Sheryl Szeinbach | EurekAlert!
Further information:
http://www.ohio-state.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>